Adjuvant hyperbaric oxygen therapy (HBO2) for treatment of necrotizing fasciitis reduces mortality and amputation rate is a 2005 journal article by Escobar SJ, Slade JB, Hunt TK and Cianci P, published in Undersea Hyperb Med 32(6). It addresses hyperbaric oxygen as an adjunct to treatment for necrotizing fasciitis, a rapidly destructive soft-tissue infection with urgent implications for surgery and critical care.
What is necrotizing fasciitis?
Necrotizing fasciitis is a severe infection that spreads through soft tissue, including the fascia, the connective layer surrounding muscles and other structures. Tissue injury can progress quickly, and the illness may lead to systemic infection, organ dysfunction and loss of viable tissue.
Treatment is time-critical and centres on urgent surgical removal of infected and dead tissue, alongside antimicrobial therapy and intensive supportive care. Hyperbaric oxygen is considered an adjunct: it cannot replace surgery or antibiotics, and its potential role has to be assessed within the full treatment plan.
What does hyperbaric oxygen add?
Hyperbaric oxygen therapy exposes a patient to oxygen at a pressure above normal atmospheric pressure, usually in a specialised chamber. The increased pressure raises the amount of oxygen dissolved in blood plasma, in addition to oxygen carried by haemoglobin.
In infected or injured tissue, oxygen availability can be limited by damage to the local blood supply, swelling and the infection itself. Greater oxygen availability may affect tissue oxygenation and aspects of host defence and wound repair. Whether those mechanisms translate into meaningful clinical benefit depends on the disease, timing and other treatment received.
- Adjunctive treatment: HBO2 is considered alongside standard care, not instead of urgent source control.
- Tissue oxygenation: pressure increases dissolved oxygen in blood and can raise oxygen delivery to tissues.
- Clinical outcomes: studies of this approach examine outcomes such as survival and limb preservation, as well as the demands and risks of treatment.
- Practical delivery: chamber access and safe transport must fit around urgent surgery and critical care.
Why is this a hyperbaric-medicine question?
Hyperbaric medicine studies how pressure and oxygen exposure affect the body, and when those effects can be used clinically. Its applications include diving-related illness and selected medical conditions in which changes in tissue oxygenation may matter. Severe soft-tissue infection brings those physiological questions into an emergency-care setting.
For diving physicians and hyperbaric clinicians, the issue is not simply whether oxygen can reach injured tissue. They must weigh the proposed biological rationale against the time-sensitive need for surgery, the patient’s stability and the feasibility of chamber treatment. This makes necrotizing fasciitis a question about integration of care as much as chamber physiology.
How should studies of adjunctive HBO2 be read?
Research on an add-on therapy must distinguish its contribution from the effects of surgery, antibiotics, intensive care and differences in how sick patients are at treatment. Comparisons can be difficult when treatment is delivered in emergency circumstances, because patient selection and timing may affect outcomes.
For a reader evaluating this area, useful questions include how the diagnosis was established, how quickly treatment began, what standard care patients received and how outcomes were defined. The title frames mortality and amputation as central outcomes; interpreting those endpoints in any clinical study also requires attention to its design and patient population.
What does the subject mean for diving practice?
Necrotizing fasciitis is not a routine diving injury. The relevance to diving medicine lies in the broader use of hyperbaric oxygen outside decompression illness, and in the clinical responsibility to separate a plausible mechanism from a proven indication for an individual patient.
Chamber treatment also has practical constraints: an acutely ill patient may need continuous monitoring, surgery or other urgent interventions. Decisions about HBO2 belong to the treating team, including hyperbaric clinicians; anyone with a medical concern related to diving should consult a physician experienced in diving medicine.
Frequently asked questions
What is necrotizing fasciitis?
Is hyperbaric oxygen a replacement for surgery or antibiotics?
Why does this topic matter to diving physicians?
Citation details
- Title: Adjuvant hyperbaric oxygen therapy (HBO2) for treatment of necrotizing fasciitis reduces mortality and amputation rate
- Authors: Escobar SJ, Slade JB, Hunt TK, Cianci P
- Year: 2005
- Published in: Undersea Hyperb Med 32(6)
- Identifiers: PMID 16509286
- Record type: Journal article
- Repository record: Rubicon Research Repository, handle 123456789/4061
This page is an original summary written by the Rubicon editors from the publication’s bibliographic record. It does not reproduce the paper, its abstract or its data; consult the publication itself for its methods and findings.
Related reading on Rubicon
- The Physiology Behind Oxygen Toxicity in Deep Dives
- Understanding Oxygen Toxicity Risks and Prevention in Diving
- Oxygen Partial Pressure: Key to Dive Safety and Performance
- Myth Busting: Clarifying Oxygen Toxicity Limits in Diving
- Hyperbaric Oxygen Therapy for Lyme Disease
- Erythromelalgia and Hyperbaric Oxygen
- More on Dive Medicine
- Browse the Research Library